Cuban Drug Reduces Infant Mortality from Respiratory Distress Syndrome

by Bidita Debnath on November 13, 2013 at 6:37 PM
 Cuban Drug Reduces Infant Mortality from Respiratory Distress Syndrome

In Cuba, the drug Surfacen reduced infant mortality due to respiratory distress syndrome in newborns to 0.2 per thousand live births in 2012.

In 1994, the mortality was 0.8 per thousand live births, according to a Cuban newspaper article, Prensa Latina reported.


Developed by specialists of the National Centre for Agricultural Health, the drug addresses the deficiency of pulmonary endogenous surfactant that is critical to maintaining lung inflation and promotes respiration, said Elaine Diaz, head of the research team.

Respiratory distress syndrome often occurs in premature infants and is usually a major cause of their deaths.

Using Surfacen decreases the requirement of artificial ventilation and encourages rapid improvement of the oxygen level in the blood, the doctor said.

The product obtained sanitary registration in 1995 and used in all neonatal intensive care units of the country as a part of maternal and child care programme of the ministry of public health.

In addition to saving the lives of many Cuban children, this drug also has a significant economic impact as it reduced imports of such medicines.

The product received a gold medal from the World Intellectual Property Organisation in 2007. It also won the annual health prize for technological innovation in 2006.

Source: IANS
Font : A-A+



Recommended Readings

Latest Research News

AI Shows Promise in Identifying ADHD
The AI method shows promise in identifying imaging biomarkers for diagnosing ADHD.
Life Expectancy Gap for Autistic Individuals Revealed
Diagnosed autistic individuals showed increased premature mortality in the UK, highlighting urgent needs to address associated inequalities.
Exploring How Hearing Impairment Shapes Dementia Risk
Study reveals a correlation between hearing impairment and distinct brain region variances, contributing to dementia.
Coffee and its Role in Neurodegenerative Disorders
Financial impact of caring for individuals with neurodegenerative disorders reaches hundreds of billions annually in the United States.
Healthcare Industry Struggles With Tech Skills Shortage
Experts emphasize that addressing the skills gap demands immediate attention and innovative solutions, including education, re-training, and significant time investment.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Cuban Drug Reduces Infant Mortality from Respiratory Distress Syndrome Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests